State-of-the-art of intrauterine contraception

被引:6
作者
Batar, Istvan [1 ]
机构
[1] Univ Debrecen, Family Planning Ctr, Dept Obstet & Gynaecol, Debrecen, Hungary
关键词
IUCDs; new devices; hormone-releasing devices; flexible devices; alloy used in IUCDs; young IUCD users; non-contraceptive use of IUCDs;
D O I
10.1080/13625180600907966
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite its nearly 100-year history, intrauterine contraception is a modern method even in the 21st century and its development is still going on. The aim of innovations is to optimize the contraceptive efficacy and to suppress as much as possible side effects and unwanted events (e.g. menstrual irregularities, expulsion). It is important that this method be made available to all those who could not resort to it earlier (young women, milligravidae, nulliparae). Currently three areas are more particularly being investigated: (1) flexible, frameless intrauterine implants, (2) levonorgestrel-releasing intrauterine systems, and (3) metal alloy intrauterine devices. Partly relying on the author's own clinical experience and based on the literature of recent years, this article reviews the present state and possibilities with regard to further development of intrauterine contraceptive devices.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 29 条
[1]   The levonorgestrel intrauterine system: more than a contraceptive [J].
Andersson, K .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 :15-22
[2]   Pregnancy during the use of levonorgestrel intrauterine system [J].
Backman, T ;
Rauramo, I ;
Huhtala, S ;
Koskenvuo, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (01) :50-54
[3]   The reliability of the anchoring concept for suspension of bioactive substances in the human uterus evaluated by measuring the removal force:: results after long-term use [J].
Batár, I ;
Wildemeersch, D .
CONTRACEPTION, 2004, 69 (06) :501-503
[4]  
BATAR I, 2001, DZEMDNIECIBA GINECOL, V3, P26
[5]  
Cao X, 2000, Eur J Contracept Reprod Health Care, V5, P135
[6]   Three-year efficacy and acceptability of the GyneFix® 200 intrauterine system [J].
Cao, XM ;
Zhang, WH ;
Zhao, X ;
Lin, N ;
Wang, LM ;
Li, CH ;
Song, LJ ;
Zhang, WJ ;
Zhang, ZH ;
Wildemeersch, D .
CONTRACEPTION, 2004, 69 (03) :207-211
[7]   Return to fertility in nulliparous and parous women after removal of the GyneFix® intrauterine contraceptive system [J].
Delbarge, W ;
Bátár, I ;
Bafort, M ;
Bonnivert, J ;
Colmant, C ;
Dhont, M ;
Fonzé, V ;
Gevers, R ;
Janssens, D ;
Lavalley, P ;
Salmin, E ;
Degueldre, M ;
Vrijens, M ;
Van Kets, H ;
Wildemeersch, D .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2002, 7 (01) :24-30
[8]   Expulsions following 1000 GyneFix insertions [J].
Dennis, J ;
Webb, A ;
Kishen, M .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2001, 27 (03) :135-+
[9]  
Fedele Luigi, 2004, Expert Opin Emerg Drugs, V9, P167, DOI 10.1517/eoed.9.1.167.32945
[10]  
Geyoushi BE, 2002, EUR J CONTRACEP REPR, V7, P7